AZD4694
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD4694, covering 2012-12-10 to 2012-12-10. Get the full timeline:
Most recent: Clinical Trial Update: An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease [Phase 1]